JAC Advance Access originally published online on February 10, 2005
Journal of Antimicrobial Chemotherapy 2005 55(4):489-495; doi:10.1093/jac/dki033
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Telithromycin activity is reduced by efflux in Streptococcus pyogenes
1 Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Carretera. de Colmenar, Km 9.1, 28034-Madrid, Spain; 2 Dipartimento di Patologia, Sezione di Microbiologia, Strada Le Grazie 8, 37134-Verona, Italy
* Corresponding author. Tel: +39-045-8027196; Fax: +39-045-584606; Email: giuseppe.cornaglia{at}univr.it
Objectives: To investigate whether telithromycin is a substrate for efflux pumps in Streptococcus pyogenes.
Methods: The distribution of telithromycin MICs was analysed for two distinct collections of Italian (n=486) and Spanish (n=210) S. pyogenes strains. The effect of an efflux mechanism was investigated using [3H]telithromycin.
Results: Telithromycin MIC ranges were 
0.004–0.06 mg/L (MIC50 and MIC90, 0.01 mg/L) in erythromycin-susceptible strains (lacking both mef and erm genes) and 0.01–1 mg/L (MIC50 and MIC90, 0.5 mg/L) in strains endowed with the M phenotype and expressing the mef(A) gene. A distinct telithromycin efflux was detected in the strains expressing the mef(A) gene, but not in those expressing the erm(B) gene, nor in the susceptible strains lacking mef(A) or erm genes. Efflux reversibility by addition of an inhibiting compound (sodium arsenate) was demonstrated. An msr-like sequence was also found in all strains effluxing telithromycin, but not in the others.
Conclusions: This study shows that telithromycin can be removed from S. pyogenes by efflux. That the efflux is related to the presence of the mef(A) gene is demonstrated, but—owing to the increasingly evident complexity of S. pyogenes efflux systems—the possibility that other genes may contribute to the efflux cannot be excluded.
Keywords: ketolides , macrolides , antimicrobial resistance
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Mazzariol, R. Koncan, L. A. Vitali, and G. Cornaglia Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae J. Antimicrob. Chemother., June 1, 2007; 59(6): 1171 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Hawkyard and R. J. Koerner The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Al-Lahham, P. C. Appelbaum, M. van der Linden, and R. R. Reinert Telithromycin-Nonsusceptible Clinical Isolates of Streptococcus pneumoniae from Europe Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3897 - 3900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Reynolds and J. H. Cove Resistance to telithromycin is conferred by msr(A), msrC and msr(D) in Staphylococcus aureus J. Antimicrob. Chemother., December 1, 2005; 56(6): 1179 - 1180. [Full Text] [PDF]
|
|
|
|
|
|
K. D. Ambrose, R. Nisbet, and D. S. Stephens Macrolide Efflux in Streptococcus pneumoniae Is Mediated by a Dual Efflux Pump (mel and mef) and Is Erythromycin Inducible Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4203 - 4209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Poole Efflux-mediated antimicrobial resistance J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51. [Abstract] [Full Text] [PDF]
|
|